A comment on “a prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia” by Zhou et al
Gespeichert in:
| Veröffentlicht in: | American journal of hematology 2020-04, Vol.95 (4), p.E103-E104 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | E104 |
|---|---|
| container_issue | 4 |
| container_start_page | E103 |
| container_title | American journal of hematology |
| container_volume | 95 |
| creator | Demirci, Ufuk Umit, Elif G. Demir, Ahmet Muzaffer |
| description | |
| doi_str_mv | 10.1002/ajh.25740 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2499303756</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2499303756</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3480-289de4231054f8f6e802268973b518b41a23acbc0643dd46cc2b342f49160f4c3</originalsourceid><addsrcrecordid>eNp1kMtKxDAUhoMoOl4WvoAccCU4Tm7NtMtBvCK40Y2bkqYpk6FtapI6dOczuNaXmycxOurO1TlwPv7D_yF0SPAZwZhO5GJ-RpMpxxtoRHAmxqlI6CYaYSZI3HG2g3a9X2BMCE_xNtphJEumWPARepuBsk2j2wC2hdXru4TOWd9pFcyLPoWmr4NR8awd-NCXA9gKaruE0noNpVYmyMK0GkwLsowwdDKYyHtYmjAHpysnVbBuANM0fQTD3NmmsGoIttOtkavXDygGeJrbHnQAWe-jrUrWXh_8zD30eHnxcH49vru_ujmf3Y0Viy3GNM1KzSkjOOFVWgmdYkpFmk1ZkZC04ERSJlWhYk1WllwoRQvGacUzInDFFdtDx-vcWPi51z7kC9u7Nr7MKc8yhtk0EZE6WVMqavGxTt4500g35ATnX_bzaD__th_Zo5_Evmh0-Uf-6o7AZA0sTa2H_5Py2e31OvIT1ZGRnw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2499303756</pqid></control><display><type>article</type><title>A comment on “a prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia” by Zhou et al</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><creator>Demirci, Ufuk ; Umit, Elif G. ; Demir, Ahmet Muzaffer</creator><creatorcontrib>Demirci, Ufuk ; Umit, Elif G. ; Demir, Ahmet Muzaffer</creatorcontrib><identifier>ISSN: 0361-8609</identifier><identifier>EISSN: 1096-8652</identifier><identifier>DOI: 10.1002/ajh.25740</identifier><identifier>PMID: 31957064</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>5-aza-2'-deoxycytidine ; Adult ; Antimetabolites, Antineoplastic - therapeutic use ; Azacitidine - therapeutic use ; Decitabine - therapeutic use ; Hematology ; Humans ; Idiopathic thrombocytopenic purpura ; Prospective Studies ; Purpura, Thrombocytopenic, Idiopathic - drug therapy</subject><ispartof>American journal of hematology, 2020-04, Vol.95 (4), p.E103-E104</ispartof><rights>2020 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3480-289de4231054f8f6e802268973b518b41a23acbc0643dd46cc2b342f49160f4c3</cites><orcidid>0000-0001-6923-1470</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajh.25740$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajh.25740$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31957064$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Demirci, Ufuk</creatorcontrib><creatorcontrib>Umit, Elif G.</creatorcontrib><creatorcontrib>Demir, Ahmet Muzaffer</creatorcontrib><title>A comment on “a prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia” by Zhou et al</title><title>American journal of hematology</title><addtitle>Am J Hematol</addtitle><subject>5-aza-2'-deoxycytidine</subject><subject>Adult</subject><subject>Antimetabolites, Antineoplastic - therapeutic use</subject><subject>Azacitidine - therapeutic use</subject><subject>Decitabine - therapeutic use</subject><subject>Hematology</subject><subject>Humans</subject><subject>Idiopathic thrombocytopenic purpura</subject><subject>Prospective Studies</subject><subject>Purpura, Thrombocytopenic, Idiopathic - drug therapy</subject><issn>0361-8609</issn><issn>1096-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtKxDAUhoMoOl4WvoAccCU4Tm7NtMtBvCK40Y2bkqYpk6FtapI6dOczuNaXmycxOurO1TlwPv7D_yF0SPAZwZhO5GJ-RpMpxxtoRHAmxqlI6CYaYSZI3HG2g3a9X2BMCE_xNtphJEumWPARepuBsk2j2wC2hdXru4TOWd9pFcyLPoWmr4NR8awd-NCXA9gKaruE0noNpVYmyMK0GkwLsowwdDKYyHtYmjAHpysnVbBuANM0fQTD3NmmsGoIttOtkavXDygGeJrbHnQAWe-jrUrWXh_8zD30eHnxcH49vru_ujmf3Y0Viy3GNM1KzSkjOOFVWgmdYkpFmk1ZkZC04ERSJlWhYk1WllwoRQvGacUzInDFFdtDx-vcWPi51z7kC9u7Nr7MKc8yhtk0EZE6WVMqavGxTt4500g35ATnX_bzaD__th_Zo5_Evmh0-Uf-6o7AZA0sTa2H_5Py2e31OvIT1ZGRnw</recordid><startdate>202004</startdate><enddate>202004</enddate><creator>Demirci, Ufuk</creator><creator>Umit, Elif G.</creator><creator>Demir, Ahmet Muzaffer</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><orcidid>https://orcid.org/0000-0001-6923-1470</orcidid></search><sort><creationdate>202004</creationdate><title>A comment on “a prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia” by Zhou et al</title><author>Demirci, Ufuk ; Umit, Elif G. ; Demir, Ahmet Muzaffer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3480-289de4231054f8f6e802268973b518b41a23acbc0643dd46cc2b342f49160f4c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>5-aza-2'-deoxycytidine</topic><topic>Adult</topic><topic>Antimetabolites, Antineoplastic - therapeutic use</topic><topic>Azacitidine - therapeutic use</topic><topic>Decitabine - therapeutic use</topic><topic>Hematology</topic><topic>Humans</topic><topic>Idiopathic thrombocytopenic purpura</topic><topic>Prospective Studies</topic><topic>Purpura, Thrombocytopenic, Idiopathic - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Demirci, Ufuk</creatorcontrib><creatorcontrib>Umit, Elif G.</creatorcontrib><creatorcontrib>Demir, Ahmet Muzaffer</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>American journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Demirci, Ufuk</au><au>Umit, Elif G.</au><au>Demir, Ahmet Muzaffer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A comment on “a prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia” by Zhou et al</atitle><jtitle>American journal of hematology</jtitle><addtitle>Am J Hematol</addtitle><date>2020-04</date><risdate>2020</risdate><volume>95</volume><issue>4</issue><spage>E103</spage><epage>E104</epage><pages>E103-E104</pages><issn>0361-8609</issn><eissn>1096-8652</eissn><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>31957064</pmid><doi>10.1002/ajh.25740</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-6923-1470</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0361-8609 |
| ispartof | American journal of hematology, 2020-04, Vol.95 (4), p.E103-E104 |
| issn | 0361-8609 1096-8652 |
| language | eng |
| recordid | cdi_proquest_journals_2499303756 |
| source | MEDLINE; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection) |
| subjects | 5-aza-2'-deoxycytidine Adult Antimetabolites, Antineoplastic - therapeutic use Azacitidine - therapeutic use Decitabine - therapeutic use Hematology Humans Idiopathic thrombocytopenic purpura Prospective Studies Purpura, Thrombocytopenic, Idiopathic - drug therapy |
| title | A comment on “a prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia” by Zhou et al |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T10%3A53%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20comment%20on%20%E2%80%9Ca%20prospective,%20multicenter%20study%20of%20low%20dose%20decitabine%20in%20adult%20patients%20with%20refractory%20immune%20thrombocytopenia%E2%80%9D%20by%20Zhou%20et%20al&rft.jtitle=American%20journal%20of%20hematology&rft.au=Demirci,%20Ufuk&rft.date=2020-04&rft.volume=95&rft.issue=4&rft.spage=E103&rft.epage=E104&rft.pages=E103-E104&rft.issn=0361-8609&rft.eissn=1096-8652&rft_id=info:doi/10.1002/ajh.25740&rft_dat=%3Cproquest_cross%3E2499303756%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2499303756&rft_id=info:pmid/31957064&rfr_iscdi=true |